2022
Placement and retrieval of bilateral iliac vein filters in patients with mega cava
Brahmandam A, Grubman S, Salem R, Davis KA, Tonnessen BH, Guzman RJ, Chaar C. Placement and retrieval of bilateral iliac vein filters in patients with mega cava. Journal Of Vascular Surgery Cases And Innovative Techniques 2022, 8: 610-615. PMID: 36248380, PMCID: PMC9556588, DOI: 10.1016/j.jvscit.2022.08.002.Peer-Reviewed Original ResearchVenous thromboembolismTherapeutic anticoagulationTemporary inferior vena cava filterInferior vena cava filterRecurrent venous thromboembolismBilateral iliac veinsInferior vena cavaVena cava filtersPulmonary embolismIliac veinVena cavaCava filtersPatientsSuccessful placementTemporary interruptionAnticoagulationContraindicationsCavaPresent reportThromboembolismEmbolismComplicationsPlacementSex differences in long-term outcomes of patients with deep vein thrombosis
Chan SM, Brahmandam A, Valcarce-Aspegren M, Zhuo H, Zhang Y, Tonnessen BH, Lee AI, Chaar C. Sex differences in long-term outcomes of patients with deep vein thrombosis. Vascular 2022, 31: 994-1002. PMID: 35502988, DOI: 10.1177/17085381221097746.Peer-Reviewed Original ResearchConceptsDeep vein thrombosisLong-term outcomesCatheter-directed thrombolysisLong-term mortalityVein thrombosisOverall mortalityFemale patientsOverall long-term mortalityBleeding-related mortalityLong-term bleedingDuration of anticoagulationRetrospective chart reviewTertiary care centerCongestive heart failureOverall mortality rateShort-term outcomesSeverity of PEMultivariable regression analysisRegression analysisSex differencesCaprini scoreRecurrent VTESystemic thrombolysisVenous thromboembolismBaseline characteristics
2004
Low-Molecular-Weight Heparin Versus Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer
Tonnessen B, Money S. Low-Molecular-Weight Heparin Versus Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer. Perspectives In Vascular Surgery And Endovascular Therapy 2004, 16: 144-146. DOI: 10.1177/153100350401600217.Peer-Reviewed Original ResearchWeight heparin groupRecurrent venous thromboembolismRecurrent thromboembolismVenous thromboembolismWeight heparinAnticoagulation groupHeparin groupOpen-label clinical trialLowmolecular-weight heparinAcute venous thromboembolismOral anticoagulant therapyDeep vein thrombosisGroup of patientsMolecular weight heparinLower mortality rateOral anticoagulantsAnticoagulant therapyPulmonary embolismVein thrombosisCancer patientsClinical trialsEffective therapyThromboembolismMortality ratePatients